CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Company Snapshot
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Zhong Xin Pharmaceutical Group Corporation Limited with three other companies in this sector in China: Shanghai Runda Medical Technology Co Ltd (2018 sales of 5.96 billion Chinese Renmimbi [US$847.35 million] of which 96% was Commerce), FUREN Group Pharmaceutical Co Ltd (6.32 billion Chinese Renmimbi [US$897.50 million] of which 80% was Pharmaceutical Industry), and Guizhou Xinbang Pharmaceutical Company Limited (6.58 billion Chinese Renmimbi [US$934.86 million] of which 64% was Pharmaceutical industry).

Sales Analysis. During the year ended December of 2018, sales at Tianjin Zhong Xin Pharmaceutical Group Corporation Limited were 6.36 billion Chinese Renmimbi (US$903.37 million). This is an increase of 11.8% versus 2017, when the company's sales were 5.69 billion Chinese Renmimbi. The sales level in 2018 was fairly close to the level five years ago: in 2013, Tianjin Zhong Xin Pharmaceutical Group Corporation Limited had sales of 6.01 billion Chinese Renmimbi. Sales of Western Medicine saw an increase of 19.0% in 2018, from 1.49 billion Chinese Renmimbi to 1.77 billion Chinese Renmimbi. Not all segments of Tianjin Zhong Xin Pharmaceutical Group Corporation Limited experienced an increase in sales in 2018: sales of Others fell 30.0% to 384.78 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
  Stock Performance Chart for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 13.33
(Figures in Chinese Renmimbi)
1 Week 0.0%   13 Weeks 0.5%  
4 Weeks -9.2%   52 Weeks 2.1%  
 
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Key Data:
  Ticker: 600329 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 6,358,622,000
(Year Ending Jan 2019).
Employees: 4,274
  Currency: Chinese Renmimbi Market Cap: 10,249,078,103
  Fiscal Yr Ends: December Shares Outstanding: 768,873,076
  Share Type: A Gu Closely Held Shares: 344,096,657
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.